PIMA524971

SSX2 Monoclonal Antibody (OTI4D10), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA524971-Each-of-1 In Stock ₹ 52,198.50

PIMA524971 - Each of 1

₹ 52,198.50

In Stock

Quantity

1

Base Price: ₹ 52,198.50

GST (18%): ₹ 9,395.73

Total Price: ₹ 61,594.23

Antigen

SSX2

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3

Gene Accession No.

Q16385

Gene Symbols

Ssx2

Immunogen

Full-length protein expressed in 293T cell transfected with human SSX2 expression vector

Quantity

100μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Clone

OTI4D10

Conjugate

Unconjugated

Gene

Ssx2

Gene Alias

cancer/testis antigen 5.2; cancer/testis antigen family 5, member 2a; CT5.2; CT5.2A; CT52; HD21; HOM-MEL-40; LOC103690782; MGC119055; MGC15364; MGC3884; Protein SSX2; putative protein SSX10; sarcoma, synovial, X-chromosome-related 2; SSX; SSX family member 2; SSX2; SSX2A; SSX2B; Synovial sarcoma, X breakpoint 2; synovial sarcoma, X breakpoint 2B; tumor antigen HOM-MEL-40

Host Species

Mouse

Purification Method

Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

6757

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA524970

--

Img

Thermo Scientific

PIMA524652

--

Img

Novus Biologicals

NBP274368G

--

Img

Novus Biologicals

NBP274368V

--

Img

Novus Biologicals

NB321792

--

Img

Thermo Scientific

PIMA525308

--

Img

Thermo Scientific

PIMA524921

--

Img

Thermo Scientific

PIMA525301

--

Description

  • SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins
  • These proteins may function as transcriptional repressors
  • They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy
  • SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas
  • This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X
  • The encoded hybrid proteins are probably responsible for transforming activity
  • Two transcript variants encoding distinct isoforms have been identified for this gene.